awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55309832-4EEFEA4F-01E4-4B28-B9E8-E625DD789EF8
Q55309832-4EEFEA4F-01E4-4B28-B9E8-E625DD789EF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55309832-4EEFEA4F-01E4-4B28-B9E8-E625DD789EF8
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
P2860
Q55309832-4EEFEA4F-01E4-4B28-B9E8-E625DD789EF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55309832-4EEFEA4F-01E4-4B28-B9E8-E625DD789EF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb10de536aada9cfeafb303690316c770d467084
P2860
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).